Filing Details
- Accession Number:
- 0001209191-21-050591
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-08-10 16:12:54
- Reporting Period:
- 2021-08-09
- Accepted Time:
- 2021-08-10 16:12:54
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
944809 | Opko Health Inc. | OPK | Pharmaceutical Preparations (2834) | 752402409 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1188834 | D Ph Jane Hsiao | Opko Health, Inc. 4400 Biscayne Blvd. Miami FL 33137 | Vice Chairman & Cto | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2021-08-09 | 10 | $3.73 | 27,599,870 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Footnotes
- Includes 3,124,713 shares received as a pro rata distribution from The Frost Group, LLC ("The Frost Group"), of which the reporting person was a member. The Frost Group effected a pro rata distribution of its 20,091,062 shares of the Issuer, pursuant to which the reporting person now has direct beneficial ownership of her pro rata share of the securities formerly held by The Frost Group. The reporting person previously reported that the shares were owned directly by The Frost Group.